0

Journal Articles

in Cardiology
 61-80 of 1797 Articles
Original Contribution |  January 02, 2013
Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials
Sana M. Al-Khatib, MD, MHS; Anne Hellkamp, MS; Gust H. Bardy, MD; et al.
JAMA. 2013;309(1):55-62. doi:10.1001/jama.2012.157182.
INCLUDES: , Supplemental Content
Editorial |  December 26, 2012
Combating the Epidemic of Heart Disease
Daniel Levy, MD
JAMA. 2012;308(24):2624-2625. doi:10.1001/jama.2012.164971.
Original Contribution |  December 26, 2012 FREE
Prevalence of and Risk Factors for Autopsy-Determined Atherosclerosis Among US Service Members, 2001-2011
Bryant J. Webber, MD; Peter G. Seguin, MD, MPH; Daniel G. Burnett, MD, MPH; et al.
JAMA. 2012;308(24):2577-2583. doi:10.1001/jama.2012.70830.
JAMA Patient Page |  December 26, 2012 FREE
Varicose Veins
Jill M. Merrigan, BA; Allen Hamdan, MD; Cassio Lynm, MA; et al.
JAMA. 2012;308(24):2638. doi:10.1001/jama.2012.4099.
INCLUDES: , Supplemental Content
Users' Guides to the Medical Literature |  December 26, 2012
How to Use a Noninferiority Trial:  Users' Guides to the Medical Literature
Sohail M. Mulla, BHSc; Ian A. Scott, MBBS, FRACP, MHA; Cynthia A. Jackevicius, PharmD, MSc; et al.
JAMA. 2012;308(24):2605-2611. doi:10.1001/2012.jama.11235.
Editorial |  December 19, 2012
A Look Ahead at the Future of Diabetes Prevention and Treatment
David E. Arterburn, MD, MPH; Patrick J. O’Connor, MD, MA, MPH
JAMA. 2012;308(23):2517-2518. doi:10.1001/jama.2012.144749.
JAMA Patient Page |  December 19, 2012 FREE
Air Travel–Related Deep Vein Thrombosis and Pulmonary Embolism
Harvey J. Sugerman, MD; Bo G. Eklöf, MD; William D. Toff, MD; et al.
JAMA. 2012;308(23):2531. doi:10.1001/jama.2012.4098.
INCLUDES: , Supplemental Content
Review |  December 19, 2012
Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention:  A Systematic Review and Meta-analysis
Anne Bellemain-Appaix, MD; Stephen A. O’Connor, MD; Johanne Silvain, MD, PhD; et al.
JAMA. 2012;308(23):2507-2516. doi:10.1001/jama.2012.50788.
INCLUDES: CME , Supplemental Content
From the Centers for Disease Control and Prevention |  December 19, 2012 FREE
Newborn Screening for Critical Congenital Heart Disease: Potential Roles of Birth Defects Surveillance Programs—United States, 2010–2011
JAMA. 2012;308(23):2452-2454. doi:10.1001/jama.2012.64597.
Preliminary Communication |  December 19, 2012
Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients:  The GAUSS Randomized Trial
David Sullivan, MD; Anders G. Olsson, MD, PhD; Rob Scott, MD; et al.
JAMA. 2012;308(23):2497-2506. doi:10.1001/jama.2012.25790.
INCLUDES: , Supplemental Content
Preliminary Communication |  December 12, 2012
Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy:  The POSEIDON Randomized Trial
Joshua M. Hare, MD; Joel E. Fishman, MD, PhD; Gary Gerstenblith, MD; et al.
JAMA. 2012;308(22):2369-2379. doi:10.1001/jama.2012.25321.
INCLUDES: , Supplemental Content
Preliminary Communication |  December 12, 2012
Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction:  The TIME Randomized Trial
Jay H. Traverse, MD; Timothy D. Henry, MD; Carl J. Pepine, MD; et al.
JAMA. 2012;308(22):2380-2389. doi:10.1001/jama.2012.28726.
Editorial |  December 12, 2012
Mixed Results for Bone Marrow–Derived Cell Therapy for Ischemic Heart Disease
Eduardo Marbán, MD, PhD; Konstantinos Malliaras, MD
JAMA. 2012;308(22):2405-2406. doi:10.1001/jama.2012.64751.
Editorial |  November 28, 2012
Heart Failure Therapy:  What Should Clinicians Believe?
James C. Fang, MD
JAMA. 2012;308(20):2144-2146. doi:10.1001/jama.2012.45418.
Editorial |  November 28, 2012
Warfarin After Bioprosthetic Aortic Valve Implantation
Shamir R. Mehta, MD, MSc; Jeffrey I. Weitz, MD
JAMA. 2012;308(20):2147-2148. doi:10.1001/jama.2012.91476.
Medical News and Perspectives |  November 28, 2012
Consumer Group Asks FDA to Warn Patients About Hypertension Combination Therapy
Mike Mitka, MSJ
JAMA. 2012;308(20):2070-2071. doi:10.1001/jama.2012.25362.
Original Contribution |  November 28, 2012 FREE
Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction
Lars H. Lund, MD, PhD; Lina Benson, MSc; Ulf Dahlström, MD, PhD; et al.
JAMA. 2012;308(20):2108-2117. doi:10.1001/jama.2012.14785.
INCLUDES: , Supplemental Content
Original Contribution |  November 28, 2012 FREE
Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction
Adrian F. Hernandez, MD, MHS; Xiaojuan Mi, PhD; Bradley G. Hammill, MS; et al.
JAMA. 2012;308(20):2097-2107. doi:10.1001/jama.2012.14795.
INCLUDES: , Supplemental Content
Original Contribution |  November 28, 2012 FREE
Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding
Charlotte Mérie, MD; Lars Køber, MD, DMSc; Peter Skov Olsen, MD, DMSc; et al.
JAMA. 2012;308(20):2118-2125. doi:10.1001/jama.2012.54506.
INCLUDES: , Supplemental Content
Original Contribution |  November 21, 2012 FREE
Fish Oil and Postoperative Atrial Fibrillation:  The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) Randomized Trial
Dariush Mozaffarian, MD, DrPH; Roberto Marchioli, MD; Alejandro Macchia, MD; et al.
JAMA. 2012;308(19):2001-2011. doi:10.1001/jama.2012.28733.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Serotonin Reuptake Inhibitor Use, Depression, and Long-Term Outcomes After an Acute Coronary Syndrome: A Prospective Cohort Study
Nina Rieckmann, PhD; Ian M. Kronish, MD, MPH; Peter A. Shapiro, MD; et al.
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Waste and Harm in the Treatment of Mild Hypertension
Iona Heath, MA, MB, BCh
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?
Kristian B. Filion, PhD; Jonathan Assayag, MSc; Laurent Azoulay, PhD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply
Daniel M. Witt, PharmD; Thomas Delate, PhD; Mark A. Crowther, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems